Hatch/Waxman Reform Bill Needed Despite FDA Rule – McCain, Schumer
This article was originally published in The Tan Sheet
Executive Summary
Legislation to reform the generic drug approval process will still be needed following issuance of FDA's final rule, Sens. John McCain (R-Ariz.) and Charles Schumer (D-N.Y.) said